<?xml version="1.0" encoding="us-ascii"?><rss version="2.0"><channel><title>Access China Management Consulting Ltd Market Research Reports</title><link>http://www.marketreportsonline.com/</link><description>Market Reports Online  XML Feed</description><item><title>China Pharmaceutical Guidebook Series (4) 2013 Edition Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medicines</title><link>http://www.marketreportsonline.com/239942-china-pharmaceuti.html</link><description>The traditional medicines in Orient, especially, the traditional Chinese medicines are always regarded by occidental as mysterious medicines. Until today not only the chemical composition of traditional Chinese medicines almost can not been expressed by a precise chemical structural formula, but also the indications of the majority of traditional Chinese medicines still can not been clearly described by the modern medical terminologies. How the Chinese drug authorities to administer the registration application for such mysterious traditional Chinese medicines? This is the fourth guidebook of the China Pharmaceutical Guidebook Series. It will provide a detailed introduction of the Chinese pharmace...</description><pubDate>Mon, 20 May 2013 00:00:00 GMT</pubDate></item><item><title>China Pharmaceutical Guidebook Series (3) 2013 Edition Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Biological Products</title><link>http://www.marketreportsonline.com/239043-china-pharmaceuti.html</link><description>This report provides a comprehensive and thorough knowledge of application for imported biological product registration with the Chinese drug regulatory authorities to guide overseas pharmaceutical manufacturers and producers to achieve a successful application for their products entry into the Chinese drug market.The biopharmaceutical industry is one of the burgeoning industries. In the field of biopharmaceuticals, vast knowledge awaits people to explore. The biopharmaceuticals are diversified and complex. In China, the development of biopharmaceutical industry is far behind the developed countries. The requirements of materials and clinical trials for registration application of biopharma...</description><pubDate>Fri, 10 May 2013 00:00:00 GMT</pubDate></item><item><title>China Pharmaceutical Guidebook Series (2) 2013 Edition Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Chemical Drugs</title><link>http://www.marketreportsonline.com/235712-china-pharmaceuti.html</link><description>Since the reform and open door policy implemented by Chinese authorities in the late 1970s, the door of the Chinese drug market began opening up to the world step by step, which gave a fillip to the imported drugs from overseas pharmaceutical manufacturers and producers. By 2012, sales of imported drugs have shared one fourth on the Chinese drug market. As China joins the World Trade Organization (WTO) and integrates more completely into the global economy, it will further open the door of a lucrative drug market for overseas pharmaceutical companies. More and more overseas pharmaceutical manufacturers and producers expect to enter such drug market and seize a larger part of such drug market. To e...</description><pubDate>Sat, 20 Apr 2013 00:00:00 GMT</pubDate></item><item><title>China Pharmaceutical Guidebook Series (1) 2013 Edition Latest Chinese Regulations for Imported Drug Registration: A Comprehensive Guidebook for Foreign Pharmaceutical Companies</title><link>http://www.marketreportsonline.com/232497-china-pharmaceuti.html</link><description>China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2012, sales on the Chinese drug market have reached RMB 926.1billion (about US$147 billion) reported by the &amp;laquo;2012:&amp;nbsp; Report of China Pharmaceutical Market&amp;raquo; published by Chinese Academy of Social Sciences. It is estimated that it will exceed RMB 1,000 billion by 2013. A series of factors, such as an increasingly ageing population, accelerating growth of urban population as well as expansion of healthcare covering urban and rural, will grow the Chinese drug market with a growth rate over 20 percent per annum in next three years. China is expected to become the second largest d...</description><pubDate>Wed, 10 Apr 2013 00:00:00 GMT</pubDate></item><item><title>Latest Guide to Chinese Medical Device GMP Regulations</title><link>http://www.marketreportsonline.com/226134-latest-guide-to-c.html</link><description>China is one of the fastest growing global economies with a fourth population in the world, and is one of the largest healthcare markets around the world. Along with sustained economic and population growth, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. Among them, medical devices represented dynamical growth since 2000s. By 2010, total value of medical devices on Chinese healthcare market has reached 120 billion RMB. It is estimated that within the next few years, Chinese medical device market will be likely to be more than 600 billion RMB, and will surpass Japan to become the second largest medical device market following the United States. The Chi...</description><pubDate>Wed, 20 Mar 2013 00:00:00 GMT</pubDate></item><item><title>Latest Guide to Chinese Pharmaceutical GMP Regulations</title><link>http://www.marketreportsonline.com/176022-latest-guide-to-c.html</link><description>China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2011, sales on the Chinese drug market have reached RMB 1550 billion (about US$246 billion), an increase of 7.08 fold over 2000 level. A series of factors, such as an increasingly ageing population, accelerating growth of urban population as well as expansion of healthcare covering urban and rural will grow the Chinese drug market with a growth rate over 25 percent per annum in next three years. China is expected to become the second largest drug market in the world by 2015.Since the reform and open door policy implemented by Chinese authorities in the late 1970s, the door of th...</description><pubDate>Fri, 20 Jul 2012 00:00:00 GMT</pubDate></item><item><title>China?s Guidebook for Pharmaceutical Patent Protection</title><link>http://www.marketreportsonline.com/90437-chinas-guidebook-.html</link><description>SynopsisChina&amp;rsquo;s Guidebook for Pharmaceutical Patent Protection is an essential resource for overseas and multinational pharmaceutical companies to achieve a successful patent protection for their intellectual property in China. This guidebook, targeting overseas and multinational pharmaceutical companies and combining case studies of patent infringement dispute in China from them, will provide a comprehensive and thorough knowledge of the Chinese patent system and legislation institution to guide overseas and multinational pharmaceutical companies step by step to achieve a successful patent protection for their intellectual property in China, which is beginning from t...</description><pubDate>Sun, 20 May 2012 00:00:00 GMT</pubDate></item><item><title>Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Biological Products China Pharmaceutical Guidebook Series (4) (4th edition)</title><link>http://www.marketreportsonline.com/90441-material-and-clin.html</link><description>The traditional medicines in Orient, especially, the traditional Chinese medicines are always regarded by occidental as mysterious medicines. Until today not only the chemical composition of traditional Chinese medicines almost can not been expressed by a precise chemical structural formula, but also the indications of the majority of traditional Chinese medicines still can not been clearly described by the modern medical terminologies. How the Chinese drug authorities to administer the registration application for such mysterious traditional Chinese medicines? This is the third guidebook of the China Pharmaceutical Guidebook Series. It will provide a detailed introduction of the Chinese pharmaceu...</description><pubDate>Sun, 20 May 2012 00:00:00 GMT</pubDate></item><item><title>Latest Chinese Guide to Industrial Access for Foreign Companies and Investors</title><link>http://www.marketreportsonline.com/158908-latest-chinese-gu.html</link><description>This Report published by Access China Management Consulting Ltd provides the detailed guidance of latest Chinese industrial policies on license of industrial access for foreign companies and investors.The Chinese government authorities issued the revised edition of 2011 for Catalogue for the Guidance of Foreign Investment Industries on December 24, 2011, which came into force as of January 30, 2012. The latest revised edition of 2011 for Catalogue for the Guidance of Foreign Investment Industries will determine the license of industrial access for foreign companies and investors&amp;rsquo; entry into the Chinese lucrative market and a global manufacturing base.How many significant change...</description><pubDate>Sun, 20 May 2012 00:00:00 GMT</pubDate></item><item><title>China Pharmaceutical Guidebook:  Latest Chinese Regulations for Imported Drug Registration</title><link>http://www.marketreportsonline.com/90436-china-pharmaceuti.html</link><description>Executive China possesses a fourth population in the world and has one of the largest drug markets round the world. By 2006, sales on the Chinese drug market have reached $12 billion dollars, an increase of 3.8 fold over 1998 level. A series of factors, such as an increasingly ageing population, accelerating growth of urban population as well as expansion of healthcare covering urban and rural, will grow the Chinese drug market with a growth rate of 20-25 percent per annum in next five years. China is expected to become the fifth largest drug market in the world by 2010.Since the reform and open door policy implemented by Chinese authorities in the l...</description><pubDate>Mon, 20 Feb 2012 00:00:00 GMT</pubDate></item><item><title>Latest Chinese Regulations for Imported Drug Registration: A Comprehensive Guidebook for Foreign Pharmaceutical Companies China Pharmaceutical Guidebook Series (1) (4th edition)</title><link>http://www.marketreportsonline.com/205393-latest-chinese-re.html</link><description>In China, the process of application and approval for imported drug registration is very complex, because the Chinese pharmaceutical authorities administer and control this process by exorbitant administrative measures and regulations, moreover, these exorbitant administrative regulations are variable and lack of transparency. Therefore, a comprehensive knowledge of the latest Chinese regulations for imported drug registration has been become an essential prerequisite for overseas pharmaceutical manufacturers and producers to achieve a successful application for their products entry into the Chinese drug market. This is the first guidebook of the China Pharmaceutical Guidebook Series. It will prov...</description><pubDate>Mon, 20 Feb 2012 00:00:00 GMT</pubDate></item><item><title>China?s Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration</title><link>http://www.marketreportsonline.com/148939-chinas-guidebook-.html</link><description>China is one of the fastest growing global economies with a fourth population in the world, and is one of the largest healthcare markets round the world. Along with sustained economic and population growth, Chinese healthcare market has maintained annually average growth rate above 16 % since 1990s. Among them, in-vitro diagnostic reagents represented dynamical growth since 2007. By 2010, total value of in-vitro diagnostic reagents on Chinese healthcare market has reached 1.5 billion US dollars, an increase of 13.3% over 2009 level.In 2009, the Chinese government vigorously launched &amp;ldquo;China&amp;rsquo;s Health-Care Reform&amp;rdquo;, developed an ambitious blueprint, in which health care system...</description><pubDate>Mon, 20 Feb 2012 00:00:00 GMT</pubDate></item><item><title>Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Chemical Drugs China Pharmaceutical Guidebook Series (2) (4th edition)</title><link>http://www.marketreportsonline.com/90439-material-and-clin.html</link><description>In China, like in other Western countries, the pharmaceutical authority ----- the SFDA requests applicant to submit complicate and reliable materials for application of drug registration. The SFDA stipulated the classification of drug registration in order to administer the application of chemical drug registration. At the same time, the SFDA collected the materials for application of chemical drug registration into four categories and 32 items in accordance with various chemical drug categories. When an application of chemical drug registration is filed, the SFDA will request applicant to not only submit designated material items in accordance with prescribed category of chemical drug to apply fo...</description><pubDate>Mon, 20 Feb 2012 00:00:00 GMT</pubDate></item><item><title>China?s Guidebook for Application and Approval of Imported Medical Device Registration</title><link>http://www.marketreportsonline.com/144945-chinas-guidebook-.html</link><description>In 2009, the Chinese government vigorously launched China&amp;rsquo;s Health-Care Reform, developed an ambitious blueprint, in which health care system will cover about 1.2 billion people by 2011. Medical devices have been widely used in the process of disease prevention, diagnosis, therapy, care and rehabilitation. It is estimated that within the next few years, Chinese medical device market is likely to be more than 600 billion RMB, and will surpass Japan to become the second largest medical device market following the United States. The Chinese medical devices market will attract more and more medical devices produced by overseas manufacturers and produce...</description><pubDate>Fri, 20 Jan 2012 00:00:00 GMT</pubDate></item><item><title>A Comprehensive Guidebook for Foreign Pharmaceutical Companies China Pharmaceutical Guidebook Series (1) (4th edition)</title><link>http://www.marketreportsonline.com/90438-a-comprehensive-g.html</link><description>In China, the process of application and approval for imported drug registration is very complex, because the Chinese pharmaceutical authorities administer and control this process by exorbitant administrative measures and regulations, moreover, these exorbitant administrative regulations are variable and lack of transparency. Therefore, a comprehensive knowledge of the latest Chinese regulations for imported drug registration has been become an essential prerequisite for overseas pharmaceutical manufacturers and producers to achieve a successful application for their products entry into the Chinese drug market. This is the first guidebook of the China Ph...</description><pubDate>Sun, 01 May 2011 00:00:00 GMT</pubDate></item><item><title>Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration: A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medicines China Pharmaceutical Guidebook Series (3) (4th edition)</title><link>http://www.marketreportsonline.com/90440-material-and-clin.html</link><description>The traditional medicines in Orient, especially, the traditional Chinese medicines are always regarded by occidental as mysterious medicines. Until today not only the chemical composition of traditional Chinese medicines almost can not been expressed by a precise chemical structural formula, but also the indications of the majority of traditional Chinese medicines still can not been clearly described by the modern medical terminologies. How the Chinese drug authorities to administer the registration application for such mysterious traditional Chinese medicines? This is the third guidebook of the China Pharmaceutical Guidebook ...</description><pubDate>Sun, 01 May 2011 00:00:00 GMT</pubDate></item><item><title>A Guide to Mergers and Acquisitions in China</title><link>http://www.marketreportsonline.com/90442-a-guide-to-merger.html</link><description>&amp;nbsp;Alongside the establishment of the State-owned Asset Supervision and Administration Commission (SASAC) of the State Council in March 2003, Chinese authorities start to orderly construct a new state-owned asset management system from top to bottom. Under the control of this new state-owned asset management system, a new wave of privatization of state-owned enterprises (SOEs) is emerging in China. As compared to the past privatization of state-owned enterprises, this new wave of privatization presents a remarkable feature &amp;mdash; the state property of enterprises has to be transacted publicly at the property trade markets. In past, local governments p...</description><pubDate>Sun, 01 May 2011 00:00:00 GMT</pubDate></item></channel></rss>